4
Changes in Ownership
Dermata Therapeutics, Inc. Filed Acc 0000905718-21-001165
Options or other derivatives
- Chief Financial Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Van Hoose Kyri K. Chief Financial Officer | 2021-09-01 | Grant or award · Stock Option (right to Buy) | +75,000 | 75,000 | D: show line 1 in the form |
Loading xslF345X03/dermata_fm4sep121.xml…